CM
CC icon

Castleark Management’s Chemours CC Stock Holding History

Castleark Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-37,475
Closed -$1.9M – 407
2017
Q3 		$1.9M Buy
37,475
+3,500
+10% +$165K 0.06% 259
2017
Q2 		$1.29M Sell
33,975
-381,180
-92% -$15M 0.04% 275
2017
Q1 		$16M Buy
+415,155
New +$12.5M 0.5% 49

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Castleark Management's CC Position: Q4 2017 in Review

Castleark Management sold out of Chemours (CC) in Q4 2017, closing a stake of 37,475 shares — an estimated $1.9M sold.

Castleark Management first reported a position in CC in Q1 2017 and held it in 3 quarters. The position peaked at $16M in Q1 2017. 537 funds tracked by Wall St. Rank hold CC as of Q4 2017.

  • Castleark Management reported no remaining Chemours position as of Q4 2017 after selling out during the quarter.
  • Castleark Management sold 37,475 Chemours shares in Q4 2017, an estimated $1.9M.
  • Castleark Management first reported a position in Chemours in Q1 2017 and held it in 3 quarters.
  • Castleark Management's Chemours position peaked at $16M in Q1 2017.
  • 537 funds tracked by Wall St. Rank held Chemours as of Q4 2017.

Based on Castleark Management's 13F filing for Q4 2017, filed 15 Feb 2018.